Illumina is at the forefront of next-generation sequencing (NGS), enabling breakthroughs in genomics, clinical diagnostics, and precision medicine. From benchtop MiSeq and NextSeq to high-throughput NovaSeq, its SBS technology ensures unmatched accuracy, scalability, and efficiency for diverse research applications.
With integrated DRAGEN software on NextSeq and NovaSeq, Illumina streamlines secondary data analysis, delivering ultra-fast, highly accurate insights directly on the instrument. This automation enhances efficiency, accelerates workflows, and reduces turnaround time for research and clinical applications.
Accelerating cancer research and enabling precision oncology diagnostics
Identifying genetic disorders and enabling early intervention
Rapid pathogen identification and outbreak surveillance
Non-invasive prenatal testing and carrier screening
Improving crop resilience and livestock health
With trusted technology and proven performance, our solutions empower scientists to push the boundaries of discovery. Whether you're looking for benchtop or production-scale sequencers, we provide the tools you need to compare features and select the right next-generation sequencing (NGS) platform for your research.
Advanced systems for high-precision sequencing and analysis. From benchtop MiSeq to high-throughput NovaSeq systems.
Optimized solutions for reliable and reproducible results across all applications and sample types.
Powerful bioinformatics tools including DRAGEN for seamless data interpretation and secondary analysis.
Trusted technology and proven performance to push the boundaries of discovery
Industry-leading base calling accuracy powered by SBS technology
From targeted to whole-genome sequencing on a single platform
Streamlined workflows with integrated DRAGEN software
Trusted by researchers and clinicians worldwide since 1998